⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
TSHA News
Taysha Gene Therapies, Inc. Common Stock
Form 8-K
sec.gov
TSHA
Taysha Gene Therapies Announces Multiple Presentations Highlighting its TSHA-102 Clinical Program at the 2026 IRSF Rett Syndrome Scientific Meeting
globenewswire.com
TSHA
Taysha Gene Therapies Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants
globenewswire.com
TSHA
Taysha Gene Therapies Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
globenewswire.com
TSHA
Form 8-K
sec.gov
TSHA
Taysha Gene Therapies Announces Completion of Dosing in REVEAL Pivotal Trial and Reports Longer-Term Clinical Data from Part A of REVEAL Phase 1/2 Trials Evaluating TSHA-102 for Rett Syndrome
globenewswire.com
TSHA
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
TSHA
Form 8-K
sec.gov
TSHA
Form 8-K
sec.gov
TSHA
Taysha Gene Therapies Reports First Quarter 2026 Financial Results and Provides Corporate Update
globenewswire.com
TSHA